For the purpose of establishing a traveller’s vaccination status, the Australian government recognised Bharat Biotech’s Coronavirus vaccine Covaxin.
Australia’s High Commissioner to India, Barry O’Farrell AO tweeted “Today, the @TGAgovau determined that Covaxin (manufactured by @BharatBiotech) vaccine would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status. Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by @AstraZenecaIn), means that many Indian citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia.”
Though administered to over 12 crore Indians, the indigenous vaccine is facing delays in WHO’s emergency approval. As a result, the Covaxin beneficiaries have missed out on opportunities to travel to European Union and the US.
Apart from Australia, countries that have approved Covaxin are Nepal, Mauritius, Oman, the Philippines, Iran, Sri Lanka, Mexico, Greece, Estonia and Zimbabwe.
Pic Courtesy – Google
- “Exclusive Interview: Tushar Kiran Moodgal on the Healing Power of Writing and Mental Health”
- Slowdown Caused By COVID Not Holding On The Climate Change: UN Report
- The clash between Trump supporters and police turns ugly; four died, 50 arrested
- “We will do our best to help India,” Biden bowed before the pressure of his own people